Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression
2003 · Neuropsychopharmacology · 258 citations
https://doi.org/10.1038/sj.npp.1300260
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.3K
Citations
13
h-index
14
i10-index
Jeffrey Apter is an academic researcher from Princeton University. The author has contributed to research in topics: Treatment of Major Depression & Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes & Cholinesterase and Neurodegenerative Diseases. The author has an h-index of 13, co-authored 23 publications.
https://doi.org/10.1038/sj.npp.1300260
https://doi.org/10.1001/archpsyc.64.6.679
https://doi.org/10.1007/s13670-015-0141-x
Click to start Chat